会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • CELLULAR IMMUNE RESPONSE-SPECIFIC ANTIGENS AND USES THEREFOR
    • 细胞免疫反应特异性抗原及其用途
    • WO1995027505A1
    • 1995-10-19
    • PCT/US1995004540
    • 1995-04-12
    • BIOMIRA, INC.LONGENECKER, B., MichaelDING, LeiREDDISH, Mark, A.KOGANTY, Raghupathi, Rao
    • BIOMIRA, INC.
    • A61K39/00
    • C07K14/70539A61K39/00C07K14/4727Y02A50/41Y02A50/412Y02A50/423Y02A50/476
    • A CMI-specific immunogenic composition, comprising: (a) a non-naturally occurring conjugate of a primary epitope which is substantially the same as a T cell epitope of a cancer-, microbial-, parasitic-, or virally infected cell-associated antigen, and of an immunomodulatory peptide, or (b) a mixture of (1) primary antigen bearing a primary epitope which is substantially the same as a T-cell epitope of a cancer-, microbial-, parasitic-, or virally infected cell-associated antigen, (2) an immunomodulatory peptide, where the conjugate of (a) and the immunomodulatory peptide of (b) have a molecular weight of less than 5,000 daltons, where said immunomodulatory peptide of (a) or (b) comprises an allopeptide moiety of at least five amino acids whose amino acid sequence corresponds essentially to that of a polymorphic region of an MHC-encoded polymorphic Class I or Class II antigen. The composition modulates a stronger cellular immune response than the humoral immune response and is useful for treatment of tumors.
    • 一种CMI特异性免疫原性组合物,其包含:(a)主要表位的非天然存在的缀合物,其与癌症,微生物,寄生虫或病毒感染的细胞相关抗原的T细胞表位基本相同 ,和免疫调节肽,或(b)(1)具有与癌,微生物,寄生虫或病毒感染细胞的T细胞表位基本上相同的主要表位的一级抗原的混合物, (2)免疫调节肽,其中(a)和(b)的免疫调节肽的缀合物具有小于5,000道尔顿的分子量,其中(a)或(b)的所述免疫调节肽包含异肽 至少5个氨基酸的部分,其氨基酸序列基本上与MHC编码的多态性I类或II类抗原的多态性区域相符。 该组合物调节比体液免疫应答更强的细胞免疫应答,并且可用于治疗肿瘤。